The present invention relates to a pharmaceutical composition comprising fingolimod, a pharmaceutically acceptable salt thereof or a phosphate derivative and a zwitterion as a stabilizer. The zwitterion can be present from about 5% to about 95% by weight of the total composition. The invention also relates to the methods of preparation of the composition and method of administration.